section name header

Pronunciation ⬇

be-KAP-lerm-in

Classifications ⬆ ⬇

Therapeutic Classification: wound/ulcer/decubiti healing agent

Pharmacologic Classification: platelet derived growth factors

Indications ⬆ ⬇

REMS


Action ⬆ ⬇

  • Promotes chemotaxis of cells involved in wound repair and enhances formation of granulation tissue.
Therapeutic effects:
  • Improved healing.

Pharmacokinetics ⬆ ⬇

Absorption: Minimal absorption (<3%).

Distribution: Action is primarily local.

Metabolism/Excretion: Unknown.

Half-Life: Unknown.

Time/Action Profile ⬆ ⬇

(improvement in ulcer healing)

ROUTEONSETPEAKDURATION
Topicalwithin 10 wkunknownunknown

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Derm: erythematous rash at application site

Misc: MALIGNANCY

Interactions ⬆ ⬇

Drug-drug:

Route/Dosage ⬆ ⬇

Availability ⬆ ⬇

Assessment ⬆ ⬇

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆ ⬇

Regranex

Code ⬆

NDC Code